Current medical guidelines discourage the use of combined oral contraceptives (COCs) among people who experience migraine ...

Migraine is often minimized as simple pain, but we must treat it as a complex neurological cascade involving cortical ...

A migraine drug called ubrogepant doesn't just reduce the severity of a migraine attack – it also dials down the non-headache symptoms in the prodrome: the hours leading up to the main event. That's ...

Credit: Axsome Therapeutics Symbravo is expected to be available in approximately 4 months. Symbravo is not substitutable with other formulations of meloxicam or rizatriptan. The Food and Drug ...

A migraine drug can help stop the devastating headaches in their tracks, allowing sufferers to go about their daily lives with little to no symptoms, a new clinical trial has found. People who took ...

The drug will be sold under the name Ubrelvy by the pharmaceutical company Allergan. It is considered effective for migraine with or without aura, referring to the sensory or visual disturbances that ...

A drug called ubrogepant may be able to prevent or reduce migraine symptoms if taken during the early signs of a migraine attack and before headache begins. The correpsonidng study was published in ...

When it comes to migraine treatments, one-size-fits-all does not apply. Fortunately, a new option is on the horizon. Atzumi — a dihydroergotamine (DHE) nasal powder — received approval from the U.S.

Researchers urge global promotion of these triptans and recommend their inclusion in the WHO Essential Medicines List to improve accessibility and standardize care. Study: Comparative effects of drug ...

Please provide your email address to receive an email when new articles are posted on . Supplementing pregabalin and topiramate with vitamin B2 or D enhanced their efficacy for preventing pediatric ...

3D render of a man with strong pain in head – Grayscale Image Researchers compared the safety and efficacy of drugs indicated for preventing migraine. Calcitonin gene-related peptide or its receptor ...